Cancer chemoprevention: scientific promise, clinical uncertainty. - Wikidata - awgldk - TriplyDB

Cancer chemoprevention: scientific promise, clinical uncertainty.

Cancer chemoprevention: scientific promise, clinical uncertainty.

http://www.wikidata.org/entity/Q34456971

about

Variations in Antioxidant Genes and Male Infertility Molecular cancer prevention: Current status and future directions Stress-activated cap'n'collar transcription factors in aging and human disease Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer LAS0811: from combinatorial chemistry to activation of antioxidant response element.Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells.The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.Dietary chalcones with chemopreventive and chemotherapeutic potential.Targeting NRF2 signaling for cancer chemoprevention.The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila Polyphenols from green tea and pomegranate for prevention of prostate cancer.Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition.Beta-glucans as immunostimulant in vertebrates and invertebrates.Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes.Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.Natural sulforaphane as a functional chemopreventive agent: including a review of isolation, purification and analysis methods.Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.Chemopreventive effect of 18β-glycyrrhetinic acid via modulation of inflammatory markers and induction of apoptosis in human hepatoma cell line (HepG2).Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.Hepatoprotective Effect of Aqueous Extract from the Seeds of Orychophragmus violaceus against Liver Injury in Mice and HepG2 Cells Cancer-Related Constituents of Strawberry Jam as Compared with Fresh Fruit.Modulatory effects of curcumin in conjunction with piperine on benzo(a)pyrene-mediated DNA adducts and biotransformation enzymes.6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines.Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.Apoptosis: the suicide solution in cancer treatment and chemoprevention.Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog.

P2860

Q26775995-5B749683-D03C-40F5-A1C5-BAA4C001389E Q26797207-3A4A4DE4-F3EA-43DF-8E16-F454A4F57940 Q28384783-7D68598B-2008-49BD-960C-28C6DC6F6217 Q28469051-20CAF4F0-D658-4A5E-A317-E39367AF845B Q33507900-FBC06B23-8A77-4F82-91C1-178643E537D3 Q33636771-4CB24B20-68F0-4BE1-841F-8E5EFCA78F9D Q33677828-0C7BCE1E-3432-41BA-80A2-7F5B403588DE Q33872540-2975716B-5E44-4B49-ABBD-041751FAFEF0 Q34248712-59D37AA1-47F8-40D4-A8C6-06C78ADE0A32 Q34279067-44562858-829D-4650-AA8A-111DA770A37C Q34975832-846FB7FF-7FEF-4B70-AC79-4AD8A6431C29 Q35001318-1A137598-2D8F-4753-AD93-9FDF3954F622 Q35091427-BF83A8AF-38E5-41E5-AE5F-CA4F2D7A066D Q35642615-ADA5DC99-8535-4C77-A494-2ABCBD61D29A Q35656210-048A6858-80DB-4C72-8F58-0B794D20F347 Q36481370-5E035081-22FA-49E6-9CFB-5B8A4D2A19DC Q36610398-9747BC5D-9DB3-432F-B4E9-32BA6BE6DC5A Q37023880-19BADD4F-4417-477F-9941-CBC3BEBAAE61 Q37077880-922826A5-BCDF-4365-BB83-5461728A87EA Q37514264-3DF2BB01-6C99-4036-A672-5A07352B10AC Q37594635-07882977-7C9F-44A6-8C1A-4E4902BFBF58 Q37638788-7DDB8700-DF94-41CF-AAEA-4745EF7F6110 Q37937673-71DE55AE-A988-446D-B90C-0CCF8F380187 Q38070195-E408A05C-783D-41BA-A04A-149733A5F063 Q38139567-F5EB8535-4500-4292-A0D5-BAE439FCA656 Q38161333-09A327F5-440A-4377-AACE-8F43593CDF90 Q38775227-D2D34F58-E65A-43F6-8878-868101A1CF36 Q38931011-8631B3B4-C685-433D-B6B7-06B67295C184 Q39023307-00914252-C313-4BF0-BD13-85235EE5C78A Q39108027-337E5275-CC96-4A2C-B147-50063B96E343 Q41034125-D9EBE08A-1C3F-40C6-A4CC-00A30D23AC2D Q43066467-7A3CB6C1-88AD-4721-A526-074CAA4058F7 Q47874549-87A36C96-8DEC-46BF-8849-0BE05440B4BA Q49707077-6CE50D8C-8633-41B2-8842-36B008F439DA Q53268565-7E282179-3B2C-4D0C-A157-A08A18743422 Q53345637-F8913BDE-1874-4D75-BC28-5E8DC38C0423 Q54250036-7117864B-574F-444C-9C5C-FBB158631C7B

P2860

Cancer chemoprevention: scientific promise, clinical uncertainty.

http://www.wikidata.org/entity/Q34456971

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cancer chemoprevention: scientific promise, clinical uncertainty.

@ast

Cancer chemoprevention: scientific promise, clinical uncertainty.

@en

Cancer chemoprevention: scientific promise, clinical uncertainty.

@nl

type

label

Cancer chemoprevention: scientific promise, clinical uncertainty.

@ast

Cancer chemoprevention: scientific promise, clinical uncertainty.

@en

Cancer chemoprevention: scientific promise, clinical uncertainty.

@nl

prefLabel

Cancer chemoprevention: scientific promise, clinical uncertainty.

@ast

Cancer chemoprevention: scientific promise, clinical uncertainty.

@en

Cancer chemoprevention: scientific promise, clinical uncertainty.

@nl

P1433

Q34456971-5E6F6467-E042-4ED7-85FA-AD8270F18306

P1476

Q34456971-FA4C7A86-FBED-4786-BB7F-19ACD5413379

P2093

Q34456971-8BC314F8-0A2D-4A2A-8970-D384ED0D90C6

Q34456971-BB8808B1-A420-4DE3-AC54-07DF4C2A962F

P2860

Q34456971-09B94709-98FA-474D-8A7C-936C9D92E926

Q34456971-0C630572-9B91-466E-9845-72E7BCE4E554

Q34456971-0E67166C-BF34-4313-BBDD-199539206220

Q34456971-1303EEAA-3DBF-490B-9AF2-E05FF9AAE5D5

Q34456971-157C45E6-E46F-4AA5-A492-1415DB340489

Q34456971-15C06DE2-0824-484C-9F1D-0368518556B0

Q34456971-190499C7-7CFB-4825-85CA-7952A28C1901

Q34456971-19891165-E4B2-411F-8CF5-88C4718369FD

Q34456971-19B1434D-191F-4D78-B701-2961A9377B71

Q34456971-1C9A4300-D2D7-4F69-A65F-789D03849E8D

P2888

Q34456971-A10F7B7C-F5FA-4666-994F-DCADA999AF53

P304

Q34456971-5A3C3024-ADAC-4BE2-B0AB-04601906468E

P31

Q34456971-18006752-14B0-446E-9A96-68B8BE7C3064

P356

Q34456971-752617A5-7977-4A94-9543-8E28DF4AB2FE

P433

Q34456971-969C65C2-913C-4853-84D6-85CE9037CD4E

P478

Q34456971-0C9865AB-616C-4B6C-8002-5B260D58F92E

P577

Q34456971-3752B57D-951C-4A9E-B727-CBB7A0A682C1

P5875

Q34456971-F9D4755B-1F6E-4615-92A1-9BBED1166A16

P6179

Q34456971-F00762C9-B0C0-4F7F-BF90-BA2E37BBECDD

P698

Q34456971-61163751-CDB9-4BEA-A0F3-BB3E3B54B2F4

P356

P1433

Nature Clinical Practice Oncology

P1476

Cancer chemoprevention: scientific promise, clinical uncertainty.

@en

P2093

Karen T Liby

http://www.w3.org/2001/XMLSchema#string

Michael B Sporn

http://www.w3.org/2001/XMLSchema#string

P2860

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

Inflammation and cancer

Statins and the risk of colorectal cancer

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Inflammation, atherosclerosis, and coronary artery disease

Inflammation in atherosclerosis

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

The STATs of cancer--new molecular targets come of age

Regulatory mechanisms controlling gene expression mediated by the antioxidant response element

P2888

P304

518-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC0319

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7559206

http://www.w3.org/2001/XMLSchema#string

P6179

1051622618

http://www.w3.org/2001/XMLSchema#string

P698

16205771

http://www.w3.org/2001/XMLSchema#string